SELECTIVE CYTOTOXICITY AGAINST HUMAN TUMOUR CELLS BY A VINDESINE-MONOCLONAL ANTIBODY CONJUGATE = CYTOTOXICITE SELECTIVE CONTRE LES CELLULES TUMORALES HUMAINES D'UN CONJUGUE VINDESINE-ANTICORPS MONOCLONALEMBLETON MJ; ROWLAND GF; SIMMONDS RG et al.1983; BRITISH JOURNAL OF CANCER; ISSN 0007-0920; GBR; DA. 1983; VOL. 47; NO 1; PP. 43-49; ABS. ENG; BIBL. 17 REF.; GRAPHArticle

ANTIBODY MEDIATED DELIVERY OF TOXIC MOLECULES TO ANTIGEN BEARING TARGET CELLSRASO V.1982; IMMUNOL. REV.; ISSN 0105-2896; DNK; DA. 1982; VOL. 62; PP. 93-117; BIBL. 2 P.Article

Antitumor properties of vindesine-monoclonal antibody conjugatesROWLAND, G. F; AXTON, C. A; MARSDEN, C. H et al.Cancer immunology and immunotherapy. 1985, Vol 19, Num 1, pp 1-7, issn 0340-7004Article

Studies of methotrexate-monoclonal antibody conjugates for immunotherapyKANELLOS, J; PIETERSZ, G. A; MCKENZIE, I. F. C et al.Journal of the National Cancer Institute. 1985, Vol 75, Num 2, pp 319-332, issn 0027-8874Article

Antitumor effect of actinomycin D entrapped in liposomes bearing subunits of tumor-specific monoclonal immunoglobulin M antibody = Effet antitumoral de l'actinomycine D encapsulé dans des liposomes portant des sous-unités de l'anticorps IgM monoclonal spécifique de la tumeurHASHIMOTO, Y; SUGAWARA, M; MASUKO, T et al.Cancer research (Baltimore). 1983, Vol 43, Num 11, pp 5328-5334, issn 0008-5472Article

Monoclonal antibodies for targeting chemotherapeutic agentsBALDWIN, R. W.Progress in experimental tumor research. 1985, Vol 29, pp 140-151, issn 0079-6263Article

Immunotherapy of melanomaPLAGNE, R.International journal of immunotherapy. 1986, Vol 2, Num 1, pp 19-21, issn 0255-9625Article

Antibody-coated liposomes: the role of non-specific antibody adsorptionSENIOR, J; WATERS, J. A; GREGORIADIS, G et al.FEBS letters. 1986, Vol 196, Num 1, pp 54-58, issn 0014-5793Article

Systemic immunotoxin therapy of cancer : advances and prospectsWAWRZYNCZAK, E. J.British journal of cancer. 1991, Vol 64, Num 4, pp 624-630, issn 0007-0920Article

Immunopharmakologische Behandlung von 9 Digitaliswergiftungen bei Kindern mit Schaf-Antidigoxin Fab = Traitement immunopharmacologique des intoxications digitaliques chez 9 enfants avec de l'antidigoxine de moutons = Immunopharmacological treatment of digitalis intoxications in 9 children with sheep antidigoxinSMOLARZ, A; ABSHAGEN, U.Monatsschrift für Kinderheilkunde. 1985, Vol 133, Num 9, pp 682-687, issn 0026-9298Article

Antibody-drug conjugates for cancer therapyREISFELD, R. A; MUELLER, B. M; SCHRAPPE, M et al.Immunology and allergy clinics of North America. 1991, Vol 11, Num 2, pp 341-358, issn 0889-8561Article

International conference on monoclonal antibody immunoconjugates for cancerAntibody immunoconjugates, and radiopharmaceuticals. 1993, Vol 6, Num 1, pp 47-95, issn 0892-7049Conference Proceedings

Measures of renal function in patients with cisplatin-related chronic renal diseaseREED, E; JACOB, J; BRAWLEY, O et al.Journal of the National Medical Association. 1991, Vol 83, Num 6, pp 522-526, issn 0027-9684Article

Radiosensitizer conjugation to the carcinoma 19-9 monoclonal antibodyBORLINGHAUS, K. P; FITZPATRICK, D. A; HEINDEL, N. D et al.Cancer research (Baltimore). 1987, Vol 47, Num 15, pp 4071-4075, issn 0008-5472Article

The cellular uptake and cytoxicity of chlorambucilmonoclonal antibody conjugatesSMYTH, M. J; PIETERSZ, G. A; MCKENZIE, I. F. C et al.Immunology and cell biology. 1987, Vol 65, Num 4, pp 315-321, issn 0818-9641Article

Immunotargeting of erythrocyte-bound streptokinase provides local lysis of a fibrin clotMUZYKANTOV, V. R; SAKHAROV, D. V; SMIRNOV, M. D et al.Biochimica et biophysica acta. 1986, Vol 884, Num 2, pp 355-362, issn 0006-3002Article

Postoperative radiation therapy and adjuvant chemoimmunotherapy in breast cancer: aspects of timing and immune competenceKLEFSTROM, P; NUORTIO, L; TASKINEN, E et al.Acta radiologica. Oncology. 1986, Vol 25, Num 3, pp 161-166, issn 0349-652XArticle

INHIBITION OF A MOUSE HEPATOMA BY THE ALKYLATING AGENT TRENIMON LINKED TO IMMUNOGLOBULINSGHOSE T; GUCLU A; RAJA RAMAN R et al.1982; CANCER IMMUNOL. IMMUNOTHER.; ISSN 0340-7004; DEU; DA. 1982; VOL. 13; NO 3; PP. 185-189; BIBL. 18 REF.Article

An overview of monoclonal antibody therapy of cancerWEINER, L. M.Seminars in oncology. 1999, Vol 26, Num 4, pp 41-50, issn 0093-7754, SUP12Conference Paper

The safety of allergen immunotherapy : A literature reviewCOOK, P. R; FARIAS, C.Ear, nose & throat journal. 1998, Vol 77, Num 5, pp 378-388, issn 0145-5613, 7 p.Article

Postoperative adjuvant immunochemotherapy with mitomycin C, tegafur, PSK and/or Ok-432 for gastric cancer, with special reference to the change in stimulation index after gastrectomyHATTORI, T; NAKAJIMA, T; TOMINAGA, S et al.Japanese journal of surgery. 1990, Vol 20, Num 2, pp 127-136, issn 0047-1909Article

Prospective randomized controlled study on bestatin in resectable gastric cancerNIMOTO, M; SAEKI, T; TOI, M et al.Japanese journal of surgery. 1990, Vol 20, Num 2, pp 186-191, issn 0047-1909Article

Effective immunochemotherapy for aggressive non-Hodgkin's lymphomaCOIFFIER, Bertrand.Seminars in oncology. 2004, Vol 31, pp 7-11, issn 0093-7754, 5 p., SUP2Article

Ciblage de molécules antitumorales par les anticorps monoclonaux : Les anticors monoclonaux = Immunotargeting of antitumor drugs : Monoclonal antibodiesMONNERET, Claude; FLORENT, Jean-Claude.Bulletin du cancer. 2000, Vol 87, Num 11, pp 829-838, issn 0007-4551Article

Postoperative immunochemotherapy including streptococcal lysate OK-432 is effective for patients with gastric cancer and serosal invasionMAEHARA, Y; OKUYAMA, T; KAKEJI, Y et al.The American journal of surgery. 1994, Vol 168, Num 1, pp 36-40, issn 0002-9610Article